ArticleBMC infectious diseases2024

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

Yunsong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.